Post job

Accelerate Diagnostics's revenue is $12.1 million.

What is Accelerate Diagnostics's revenue?

Accelerate Diagnostics's annual revenue is $12.1M. Zippia's data science team found the following key financial metrics about Accelerate Diagnostics after extensive research and analysis.
  • Accelerate Diagnostics's revenue growth from 2009 to 2023 is 849.61%.
  • Accelerate Diagnostics has 287 employees, and the revenue per employee ratio is $42,017.
  • Accelerate Diagnostics's peak quarterly revenue was $3.9M in 2022(q2).
  • Accelerate Diagnostics peak revenue was $12.8M in 2022.
  • Accelerate Diagnostics annual revenue for 2022 was 12.8M, 8.23% growth from 2021.
  • Accelerate Diagnostics annual revenue for 2023 was 12.1M, -5.43% growth from 2022.

On this page

Most recent quarter revenue
$3.0M (Q2'2024)
Company most recent quarter revenue
Peak revenue
$12.8M (2022)
Company peak revenue
Revenue / employee
$42,017
Company revenue / employee

Zippi applies for you, and finds you a job.

Floating question marks illustration
Most recent quarter revenue
$3.0M (Q2'2024)
Company most recent quarter revenue
Peak revenue
$12.8M (2022)
Company peak revenue
Revenue / employee
$42,017
Company revenue / employee

Accelerate Diagnostics historical revenue

Accelerate Diagnostics's peak revenue was $12.8M in 2022. The peak quarterly revenue was $3.9M in 2022(q2).

Accelerate Diagnostics's revenue increased from $1.3m in 2009 to $12.1M currently. That's a 849.61% change in annual revenue.

Accelerate Diagnostics annual revenue

$13M
$10M
$8M
$5M
$3M
$0
2018
2019
2020
2021
2022
2023

Accelerate Diagnostics annual revenue over time

Fiscal year / yearAccelerate Diagnostics revenue
2009$1.3M
2010$2.2M
2011$1.1M
2012$18,000
2013$48,000
2014$122,000
2015$147,000
2016$246,000
2017$4.2M
2018$5.7M
2019$9.3M
2020$11.2M
2021$11.8M
2022$12.8M
2023$12.1M

Rate Accelerate Diagnostics' financial transparency

Zippia waving zebra

Accelerate Diagnostics annual growth

Accelerate Diagnostics saw the greatest revenue growth in 2017, when revenue increased by 1,597.97%.

Accelerate Diagnostics had the lowest revenue growth in 2012, when revenue changed by -98.39%.

Accelerate Diagnostics annual growth rate over time

YearAccelerate Diagnostics growth
2010
77%
2011
-50%
2012
-98%
2013
167%
2014
154%
2015
20%
2016
67%
2017
1598%
2018
36%
2019
64%
2020
20%
2021
6%
2022
8%
2023
-5%

Accelerate Diagnostics quarterly revenue over time

  • Q1
  • Q2
  • Q3
  • Q4
$4M
$3M
$2M
$2M
$773,000
$0
2020
2021
2022
2023
2024

Accelerate Diagnostics quarterly growth rate over time

YearQ1Q2Q3Q4
2012----$19,033
2013$16,000$7,000$13,000$12,000
2014$14,000$13,000$16,000$79,000
2015$14,000$19,000$92,000$22,000
2016$163,000$20,000$24,000$39,000
2017$530,000$699,000$828,000$2.1M
2018$801,000$1.7M$1.4M$1.8M
2019$1.8M$1.8M$2.3M$3.5M
2020$2.3M$2.1M$3.6M$3.1M
2021$2.5M$2.8M$3.1M$3.3M
2022$3.0M$3.9M$3.0M$3.0M
2023$2.8M$2.9M$3.3M$3.0M
2024$2.9M$3.0M--

Accelerate Diagnostics jobs nearby

Do you work at Accelerate Diagnostics?

Did Accelerate Diagnostics meet its revenue projections?

Accelerate Diagnostics financial information

CEOJack Phillips
IndustryPharmaceuticals, Biotechnology & Life Sciences
Company TypePublic
Employees Number287
Date Founded2004
HeadquartersTucson, Arizona
Number of Locations2
Revenue$12.1M
Net Income-$62,493,000
Gross Proft$2.6M (2023)
EBITDA($30.6M) (2014)
PE Ratio-18.50
Tax Rate-0.0%
Market Capitalization$1.1B
Total Assets$65,015,000
TickerAXDX

Accelerate Diagnostics jobs you might like

Accelerate Diagnostics financing

Accelerate Diagnostics received early financing of $275.0K on 2010-03-23.

SeriesRound sizeDate
Series Unknown$275K03/2010
Series Unknown$14.4M07/2012
Series Unknown$20M08/2013
Series Unknown$3.3M08/2013
Post Ipo Equity$45M05/2014
Post Ipo Equity$19.5M06/2014
Post Ipo Equity$109M12/2015
Post Ipo Equity$1M08/2019
Post Ipo Equity$32M03/2021
Grant$578K06/2021
Post Ipo Equity$4M04/2022

Accelerate Diagnostics investors

InvestorsSecurity type
Jack W. Schuler Living TrustPost Ipo Equity
Oracle CorporationPost Ipo Equity
Schuler Family FoundationPost Ipo Equity
CARB XGrant

Accelerate Diagnostics revenue FAQs

Search for jobs

Zippia gives an in-depth look into the details of Accelerate Diagnostics, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Accelerate Diagnostics. The employee data is based on information from people who have self-reported their past or current employments at Accelerate Diagnostics. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Accelerate Diagnostics. The data presented on this page does not represent the view of Accelerate Diagnostics and its employees or that of Zippia.

Accelerate Diagnostics may also be known as or be related to ACCELERATE DIAGNOSTICS INC, Accelerate Diagnostics, Accelerate Diagnostics Inc, Accelerate Diagnostics, Inc and Accelerate Diagnostics, Inc.